Light Application Patents (Class 607/88)
  • Patent number: 11965776
    Abstract: A method for quantifying an exposure dose for a surface is disclosed. The method may include emitting one or more beams of 222 nm light onto a portion of the surface using one or more far ultraviolet (UV) light sources capable of emitting 222 nm light, the portion of the surface being coated with one or more fluorescent coatings. The method may include capturing images of the portion of the surface. The method may include adjusting one or more image characteristics for the captured images using one or more filtering methods. The method may include generating a histogram of the adjusted images based on the one or more filtering methods. The method may include determining a pixel surface area for the generated histogram. The method may include calculating the exposure dose for the surface based on the generated pixel surface area and a predetermined calibration curve.
    Type: Grant
    Filed: August 10, 2021
    Date of Patent: April 23, 2024
    Assignee: B/E AEROSPACE, INC.
    Inventors: Thomas Martz, John D. Edquist, David C. McConnell, Steven Poteet, Katherine Urena Pimentel
  • Patent number: 11890460
    Abstract: A system and method for aiding in the proper placement of ECG electrodes and other resuscitation parameters. The system includes motion sensors disposed on the ECG electrodes, and a defibrillator control system operable to interpret motion signals from the motions sensors to determine that an electrode is in motion, and thus being handled by rescuer setting up the system for use, and, based on this determination, prompt the rescuer to place the electrode in its intended location on the body of the patient. The control system may also be operable to determine relative motion and/orientation of the motion sensors and control resuscitation based on the relative motion and/orientation of the motion sensors.
    Type: Grant
    Filed: February 25, 2020
    Date of Patent: February 6, 2024
    Assignee: ZOLL Medical Corporation
    Inventors: Michael J. Riley, Gary A. Freeman, Frederick J. Geheb, Annemarie E. Silver, Lisa M. Campana
  • Patent number: 11887449
    Abstract: A security system. The security system has a camera operated by a microcontroller. The microcontroller has a logic to scan the images collected by the camera and determine if a dangerous event is happening. After a dangerous event is identified, the microcontroller activates a security system. The security system will activate several functional features including a speaker, a light and a door lock.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: January 30, 2024
    Inventor: Elvis Maksuti
  • Patent number: 11874462
    Abstract: An intraocular micro-display (IOMD) system includes an auxiliary head unit. The auxiliary head unit includes a frame for mounting to a head of a user, a scene camera module mounted in or on the frame in a forward-facing orientation, a gaze tracking module disposed in or on the frame and configured to monitor an eye of the user, and an auxiliary controller. The auxiliary controller includes for: acquiring a scene image with the scene camera module, determining a gazing direction of the eye based upon gaze direction data from the gaze tracking module, identifying a sub-portion of the scene image based upon the gazing direction, and wirelessly relaying the sub-portion of the scene image to an IOMD implant within the eye for displaying to a retina of the eye.
    Type: Grant
    Filed: March 23, 2020
    Date of Patent: January 16, 2024
    Assignee: Twenty Twenty Therapeutics LLC
    Inventors: Shungneng Lee, Supriyo Sinha, Dimitri Azar
  • Patent number: 11865356
    Abstract: Technology for a light therapy device is disclosed. The light therapy device can comprise: a housing; and a combination of light sources coupled to the housing in an orientation operable to radiate a subject, and provide light therapy from the combination of light sources. The combination of light sources can include: a first discrete light source configured to emit light at a wavelength limited to between about 500 nanometers (nm) to about 700 nm; a second discrete light source configured to emit light at a wavelength limited to between about 700 nm to about 850 nm; a third discrete light source configured to emit light at a wavelength limited to between about 800 nm to about 900 nm; and a fourth discrete light source configured to emit light at a wavelength limited to between about 850 nm to about 1050 nm.
    Type: Grant
    Filed: September 2, 2021
    Date of Patent: January 9, 2024
    Assignee: Theralight, LLC
    Inventors: Charles Vorwaller, Justin Vorwaller, Lin Yang, Brian H. Probst
  • Patent number: 11857731
    Abstract: Various embodiments relate to the field of communications technologies, and provide a light adjustment method and a terminal to resolve a problem that an existing light therapy device cannot flexibly adjust light based on a light requirement of a user and cannot more intelligently adjust a circadian rhythm of the user. In those embodiments, an awake time period and a sleep time period of a user is determined by the terminal, and parameter thresholds in the awake time period and the sleep time period is determined by the terminal. In those embodiments, a light parameter in a current time period is obtain by the terminal, and based on the light parameter in the current time period, a light parameter of light emitted by a light source device is then adjusted by the terminal.
    Type: Grant
    Filed: May 28, 2019
    Date of Patent: January 2, 2024
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Guangming Guo, Xiaoping Huang, Xi Huang, Chenxi Lu
  • Patent number: 11857733
    Abstract: A method and apparatus for stimulating neural activity in the brain of a user of an apparatus with a display screen by causing at least one portion of the display screen to flicker in a controlled manner and utilizing the apparatus to measure an effect on a user exposed to the flicker for a time.
    Type: Grant
    Filed: May 10, 2023
    Date of Patent: January 2, 2024
    Assignee: SYMBOLICS INC.
    Inventor: Russell Noftsker
  • Patent number: 11833101
    Abstract: A rejuvenation and massage device is provided for treating mucosa tissue, such as vaginal tissue, affected by Vaginal Relaxation Syndrome (VRS) or other conditions, through vibration, thermal loading, and light emittance for a duration of time. In one embodiment, the device is an insertable device that includes Low-Level Laser Light (LLLT) therapy to treat the vaginal tissue. The light emittance by one or more light emitters is in a range sufficient to provide therapeutic effects through light radiation. To enhance the therapeutic effects of light radiation provided by the device, the device is configured to provide increased energy density into target tissue of vaginal muscles though a light configuration component (e.g., a focusing component, such as a concave lens assembly, a convex assembly, a pre-lensed light emitter or other focusing optical mechanism) associated with the light emitter that concentrates the light emitted from the light emitter.
    Type: Grant
    Filed: August 10, 2021
    Date of Patent: December 5, 2023
    Assignee: Joylux, Inc.
    Inventors: Colette Courtion, Nicolas Loebel, Roger Andersen, Kevin Bailey, Matthew Bailey, Yana Klimava
  • Patent number: 11813475
    Abstract: In certain embodiments a light therapy system (e.g., phototherapy device), such as for treatment of Alzheimer's disease, depression, dementia, short-term memory, or for improved learning, improved athletic performance or improved cognitive performance, is provided where the light system comprises a blue light source that operates at a frequency in the range from 20 to 50 Hz (preferably around 40 Hz), whereby the system enables retinal ganglion cells of a human to be exposed in order to stimulate brain waves (gamma oscillations in the human's brain).
    Type: Grant
    Filed: February 14, 2018
    Date of Patent: November 14, 2023
    Assignees: The Regents of the University of California, Danmarks Tekniske Universitet
    Inventors: Jes Broeng, Paul Michael Petersen, Ngoc Mai Thi Nguyen, Lance Kriegsfeld
  • Patent number: 11806066
    Abstract: Ablation catheters and systems include flexible catheter tips with a distal needle or ports for delivery of an ablative agent to a target tissue. Pressure monitoring during ablation ensure operation is performed within safe limits and with desired efficacy. Positioning elements help maintain the devices in the proper position with respect to the target tissue and also prevent the passage of ablative agent to normal tissues.
    Type: Grant
    Filed: May 31, 2019
    Date of Patent: November 7, 2023
    Inventor: Virender K. Sharma
  • Patent number: 11806301
    Abstract: A treatment that regenerates cells, remodels collagen, and reverses atrophy to restore full sexual function of human genitalia.
    Type: Grant
    Filed: September 1, 2022
    Date of Patent: November 7, 2023
    Inventor: Jeffrey Nuziard
  • Patent number: 11779777
    Abstract: Methods for a generally safe and effective therapy to lower excessive and chronic inflammation via the promotion of the body's powerful anti-inflammatory Interleukin-10 cytokine and re-activation of dormant T regulatory cells are provided. The methods balance the safety and efficacy of both Interleukin-10 (IL-10) and Treg optimization with excessive risk of UV overexposure to treat and improve several chronic autoimmune inflammatory conditions.
    Type: Grant
    Filed: September 6, 2022
    Date of Patent: October 10, 2023
    Assignee: LumaVive LLC
    Inventors: Kenneth N. Oif, Michael G. Kaufman
  • Patent number: 11771917
    Abstract: In one aspect, a system for in vivo and transcranial stimulation of brain tissue of a subject may include at least one light source, a controller to control operation of the light source, a signal detecting unit and a processor configured to receive signals from the signal detecting unit, analyze the signals and generate a feedback signal to the controller to control the light source until optimal results are obtained. In one embodiment, the light source is a laser instrument and the wavelength can range from 800 to 1100 nm. In another embodiment, the irradiance of the laser instrument can range from 50 to 1000 mW/cm2.
    Type: Grant
    Filed: September 29, 2020
    Date of Patent: October 3, 2023
    Inventor: Li-Da Huang
  • Patent number: 11737183
    Abstract: Methods and systems as described herein may be used for independently controlling the color temperature, intensity, and/or circadian response (CR) of one or more light sources (e.g., discrete-spectrum light sources) to adjust one or more color temperature, intensity, and circadian metrics in a space. For example, a light fixture may have four controllable light sources, a warm CR boost, cool CR boost, warm non-boost CR and a cool non-boost CR to independently control intensity, color temperature, and CR outputs.
    Type: Grant
    Filed: December 6, 2019
    Date of Patent: August 22, 2023
    Assignee: Lutron Technology Company LLC
    Inventors: Craig A. Casey, Brent Protzman
  • Patent number: 11724122
    Abstract: Provided is a laser patch, and the laser patch includes: a patch body having a through hole for laser transmission; a circuit substrate disposed in the patch body; a built-in battery disposed, facing the circuit substrate, in the patch body; a laser diode element electrically connected to the circuit substrate and emitting a low-output laser beam to the outside of the patch body by using its own power coming from the built-in battery; and a charging terminal provided in the patch body for selectively supplying electricity to the built-in battery from an external charger.
    Type: Grant
    Filed: September 16, 2021
    Date of Patent: August 15, 2023
    Assignee: WELLSCARE CO., LTD
    Inventor: Sung Won Lee
  • Patent number: 11680904
    Abstract: Bio-photonic devices or target cells and cell cultures including bio-photonic devices and target cells are provided. Methods of preparing cell cultures including bio-photonic devices and target cells are also provided. Methods of analyzing the electrophysiology of target cells using the cell cultures are provided. Systems for analyzing the electrophysiology of target cells are also provided.
    Type: Grant
    Filed: May 2, 2017
    Date of Patent: June 20, 2023
    Assignee: The George Washington University
    Inventors: Emilia Entcheva, Aleksandra Klimas
  • Patent number: 11673001
    Abstract: The present disclosure provides a circadian rhythm correcting apparatus including a bio-illuminance measuring part configured to measure bio-illuminance of external light, a light source configured to irradiate light of a circadian wavelength band toward a retinal ganglion cell, a light source driver configured to drive the light source by supplying power to the light source, and a controller configured to control the light source driver on the basis of the bio-illuminance measured by the bio-illuminance measuring part, to correct the circadian rhythm.
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: June 13, 2023
    Assignee: Kookmin University Industry Academy Cooperation Foundation
    Inventors: Young Rag Do, Ji Hye Oh
  • Patent number: 11666776
    Abstract: A handheld light treatment device that aims to provide a wide variety of uses in personal care and household cleaning. The device contains a panel with light sources positioned behind a translucent or transparent head plate, to which is attachable an applicator disc and, optionally, applicator disc attachments with selected functionalities. The light panel shines light of different frequencies that may be useful for cleaning and sanitizing various surfaces. The applicator disc and applicator disc attachments have a substantially translucent or transparent base, allowing light from the light sources to shine through the head plate as well as applicator disc and applicator disc attachment, and the applicator disc to rotate while the light panel remains fixed. The applicator disc and applicator disc attachments may have bristles or other surface elements to facilitate cleaning or other uses, and the device may dispense an ingredient.
    Type: Grant
    Filed: September 23, 2020
    Date of Patent: June 6, 2023
    Inventor: Johann Verheem
  • Patent number: 11660449
    Abstract: A system (20) includes a plurality of electrodes (28), one or more radiofrequency (RF) generators (30), and a controller (36). The controller is configured to treat skin of a user (22), using one or more decision rules, responsively to multiple ascertained values of at least one parameter, by iteratively ascertaining at least one respective value of the ascertained values, by applying at least one of the decision rules to the ascertained value, identifying a treatment setting from among multiple treatment settings, and causing the RF generators to cause one or more RF currents to pass, through the skin, between at least some of the electrodes in accordance with the identified treatment setting. The controller is further configured to modify at least one of the decision rules in response to the ascertained values. Other embodiments are also described.
    Type: Grant
    Filed: June 10, 2019
    Date of Patent: May 30, 2023
    Assignee: AIGAIN BEAUTY LTD.
    Inventor: Daniel Eduardo Lischinsky
  • Patent number: 11648218
    Abstract: Systems and methods for treating a fibrous mass, such as one of a plantar fibroma or related type, are disclosed. In one exemplary implementation, a method may comprise identifying a location of the fibrous mass and non-surgically delivering electromagnetic energy to the fibrous mass. Embodiments may include delivering the energy via an Nd:Yag laser at various specified parameters, such as duration, pulse count, and tissue depth, among others.
    Type: Grant
    Filed: January 5, 2021
    Date of Patent: May 16, 2023
    Inventor: Darin Bocian
  • Patent number: 11642167
    Abstract: According to some embodiments, a medical instrument (for example, an ablation device) comprises an elongate body having a proximal end and a distal end, an energy delivery member positioned at the distal end of the elongate body, a first plurality of temperature-measurement devices carried by or positioned within the energy delivery member, the first plurality of temperature-measurement devices being thermally insulated from the energy delivery member, and a second plurality of temperature-measurement devices positioned proximal to a proximal end of the energy delivery member, the second plurality of temperature-measurement devices being thermally insulated from the energy delivery member.
    Type: Grant
    Filed: May 21, 2020
    Date of Patent: May 9, 2023
    Assignee: Epix Therapeutics, Inc.
    Inventors: Eric Andrew Schultheis, Josef Vincent Koblish, Dorin Panescu
  • Patent number: 11617896
    Abstract: A medical wound healing accelerator having a body that is removably attached on a fixing pin, of an external fixator for fractures, that is insertable into a bone through skin is provided. The device can further include a plurality of light source units arranged on one surface of the body to emit light and provide a beneficial effect to the wound, and a controller electrically connected to the light source units. An osteomyelitis treatment device having an insert that is insertable into an osteomyelitis part in a human body, and a plurality of light-emitting members provided to the insert to emit light is also provided. The plurality of light-emitting members can be spaced apart from each other, and a part of the insert can be cut or bent to correspond to the shape of the osteomyelitis part.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: April 4, 2023
    Assignee: KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
    Inventors: Jong Woong Park, Tae Jin Song
  • Patent number: 11619918
    Abstract: Embodiments are disclosed for a method. The method includes generating statistical models of circadian rhythms based on circadian rhythm data generated by mobile computing devices of occupants of a building having a building automation system. The method also includes identifying room occupants of a room disposed within the building. Additionally, the method includes determining ambient settings for an ambient system operated by the building automation system based on a subset of the statistical models, wherein the subset corresponds to the identified room occupants. The method further includes determining a trade-off ambient setting based on the ambient settings.
    Type: Grant
    Filed: September 28, 2020
    Date of Patent: April 4, 2023
    Assignee: International Business Machines Corporation
    Inventors: Marco Luca Sbodio, Caroline A. O'Connor, Omar O'Sullivan, Seshu Tirupathi
  • Patent number: 11589817
    Abstract: A contact lens according to an embodiment of the present disclosure includes: a lens section that is worn on an eyeball; an acquisition section that is provided in the lens section and acquires biological information; and an output section that outputs the biological information acquired by the acquisition section to an external apparatus to be worn on a human body. The output section has one or a plurality of coil antennas extending along a front surface of the lens section, and a capacitor that is coupled to the one or the plurality of coil antennas in series or in parallel.
    Type: Grant
    Filed: August 7, 2018
    Date of Patent: February 28, 2023
    Assignees: Sony Corporation, Sony Semiconductor Solutions Corporation
    Inventors: Masanori Iwasaki, Takayuki Hirabayashi, Naoto Yamaguchi, Tsukasa Yoshimura, Masakazu Yajima, Fumiko Shiga, Ken Hayakawa
  • Patent number: 11577094
    Abstract: Systems and methods for treating sexual dysfunction using transcranial photobiomodulation (t-PBM) with near infrared light (NIR) are provided. In particular, a device configured for treating a disorder of a subject, the device can have a power source and a light source configured to receive power from the power source to cause the light source to emit near infrared light, wherein the near-infrared light has a wavelength of 600 nm to 1400 nm. The device has a processor and a housing configured to position the light source to deliver the near infrared light to a region of interest of the subject via transcranial photobiomodulation in a dosimetry and duration sufficient to treat the disorder.
    Type: Grant
    Filed: April 9, 2018
    Date of Patent: February 14, 2023
    Assignee: The General Hospital Corporation
    Inventor: Paolo Cassano
  • Patent number: 11565131
    Abstract: An optical stimulation system includes a light source; an optical lead coupled, or coupleable, to the light source; at least one of a calibration table or a calibration formula, generated by a calibration procedure specifically using the light source and the optical lead of the optical stimulation system; and a control unit coupled, or coupleable, to the light source. The control module includes a memory to store the at least one of the calibration table or the calibration formula, and a processor coupled to the memory and configured for receiving a target light output level, using the at least one of the calibration table or the calibration formula to determine at least one operational parameter for generating the target light output level, and directing the light source, using the at least one operational parameter, to generate light at the target light output level.
    Type: Grant
    Filed: March 19, 2019
    Date of Patent: January 31, 2023
    Assignees: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION, COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (“CEA”)
    Inventors: Dennis Allen Vansickle, Adam Thomas Featherstone, Claude Chabrol, Michael A. Moffitt, Sarah Renault, Adrien Poizat
  • Patent number: 11554048
    Abstract: Systems and methods of treating meibomian and sebaceous gland dysfunction. The methods include reducing oxygen concentration in the environment of one or more dysfunctional meibomian and sebaceous glands, thereby restoring a hypoxic status of one or more dysfunctional meibomian and sebaceous glands. The reducing of the oxygen concentration is accomplished by restricting blood flow to the one or more dysfunctional meibomian and sebaceous glands and the environment of one or more dysfunctional meibomian sebaceous glands. The restricting of the blood flow is accomplished by contracting or closing one or more blood vessels around the one or more dysfunctional meibomian or sebaceous glands. The methods also include giving local or systemic drugs that lead to the generation of hypoxia-inducible factors in one or more dysfunctional meibomian and sebaceous glands.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: January 17, 2023
    Assignee: The Schepens Eye Research Institute, Inc.
    Inventors: David A. Sullivan, Yang Liu
  • Patent number: 11541249
    Abstract: Certain examples involve controlling a circadian impact of a lighting system. For instance, a lighting system includes a first lighting fixture. The first lighting fixture includes at least one lighting element to illuminate a first space and a first controller to control a first light output of the at least one lighting element. Additionally, the lighting system includes a first background circadian system that provides a first modifying factor to the first controller of the first lighting fixture. The first modifying factor is associated with a first circadian impact profile that specifies a first circadian impact level in the first space. Further, the first controller of the first lighting fixture controls the first light output based on the first modifying factor.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: January 3, 2023
    Assignee: ABL IP HOLDING LLC
    Inventors: David P. Ciccarelli, Daniel Aaron Weiss, Benjamin Marshall Suttles
  • Patent number: 11524173
    Abstract: Systems and methods for phototherapeutic modulation of nitric oxide in mammalian tissue include use of a first wavelength and first radiant flux of light to stimulate enzymatic generation of nitric oxide, and use of a second wavelength and second radiant flux of light to stimulate release of nitric oxide from endogenous stores of nitric oxide. Pulsed light and/or partially non-overlapping light impingement windows may be used. Non-coherent light impinged on tissue may include a peak wavelength in a range of from 410 nm to 440 nm in the absence of light emissions having a peak wavelength of from 600 nm to 900 nm.
    Type: Grant
    Filed: December 10, 2019
    Date of Patent: December 13, 2022
    Assignee: KNOW Bio, LLC
    Inventors: Nathan Stasko, Nicholas William Medendorp, Jr., Gerald H. Negley, Katelyn P. Reighard
  • Patent number: 11523095
    Abstract: An image projection system includes a first transmitter configured transmit pixel light pulses along a transmission path to be projected onto an eye to render a projection image thereon; a second transmitter configured to generate infrared (IR) light pulses transmitted along the transmission path to be projected onto the eye and reflected back therefrom as reflected IR light pulses on a reception path; a coaxial scanning system arranged along the transmission and reception paths; an eye-tracking sensor configured to generate a retina image of the eye based on reflected IR light pulses, and process the retina image to determine a fovea region location of the eye; and a system controller configured to render the projection image based on the fovea region location, wherein the projection image is rendered with a higher resolution in the fovea region and is rendered with a lower resolution outside of the fovea region.
    Type: Grant
    Filed: December 21, 2020
    Date of Patent: December 6, 2022
    Assignee: Infineon Technologies AG
    Inventor: Boris Kirillov
  • Patent number: 11504544
    Abstract: A personal therapy compartment includes a base of size to receive a human patient. The compartment includes a bed in the base said bed being made of a light transmissive material. An array of lights mounted is below the bed to transmit light onto a body supported on the bed. A control panel controls at least the wavelength, intensity and pulsation of the light.
    Type: Grant
    Filed: July 7, 2020
    Date of Patent: November 22, 2022
    Assignee: VISIBELLE DERMA INSTITUTE, INC.
    Inventor: Steven J. Daffer
  • Patent number: 11497930
    Abstract: A ring has an open top side and side walls that circumscribe a central region for receiving a phototherapy subject. The side walls include a work surface that is configured to receive visible light through the open top side and reflect the visible light toward the central region for phototherapy. The work surface includes a first surface that is a diffuse reflector and a second surface that is a specular reflector.
    Type: Grant
    Filed: November 26, 2019
    Date of Patent: November 15, 2022
    Assignee: AG IP HOLDING LLC
    Inventor: Patrick Kenneth Powell
  • Patent number: 11497927
    Abstract: A plurality of devices that provide examination/diagnosis and/or treatment benefits to a patient are presented. The device including a plurality of light sources that provide for the emission of light in a plurality of wavelength ranges, wherein the plurality of light sources are activated by a sensor, configured to determine a proximity of the device to a patient, to control an application of a voltage to selected one of the plurality of light sources for a predetermined time period.
    Type: Grant
    Filed: July 8, 2021
    Date of Patent: November 15, 2022
    Assignee: Designs for Vision, Inc.
    Inventors: Liviu Steier, Richard E. Feinbloom
  • Patent number: 11484730
    Abstract: Systems and methods for phototherapeutic modulation of nitric oxide in mammalian tissue include use of a first wavelength and first radiant flux of light to stimulate enzymatic generation of nitric oxide, and use of a second wavelength and second radiant flux of light to stimulate release of nitric oxide from endogenous stores of nitric oxide. Pulsed light and/or partially non-overlapping light impingement windows may be used. Non-coherent light impinged on tissue may include a peak wavelength in a range of from 410 nm to 440 nm in the absence of light emissions having a peak wavelength of from 600 nm to 900 nm.
    Type: Grant
    Filed: December 10, 2019
    Date of Patent: November 1, 2022
    Assignee: KNOW Bio, LLC
    Inventors: Nathan Stasko, Nicholas William Medendorp, Jr., Gerald H. Negley, Katelyn P. Reighard
  • Patent number: 11479748
    Abstract: A device for DNA repair phototherapy is provided. A method of use for the device to provide DNA phototherapy to damaged DNA is also disclosed.
    Type: Grant
    Filed: March 27, 2020
    Date of Patent: October 25, 2022
    Assignee: The Regents of the University of California
    Inventors: Veronica Gomez-Godinez, Michael Berns, Shirli Cohen, Matthew Ono, Daryl Preece
  • Patent number: 11458329
    Abstract: The invention comprises componentry and devices for light therapy application to a patient in need thereof. The present invention relates to controllers for light therapy devices, light delivery elements, light guides, light guide arrangements configured to deliver personalized light therapy to one or more patients, with related componentry, dosage, and configurations of light therapy delivery elements (e.g., bandages, garments, braces, inserts etc.) suitable to deliver light therapy to one or more patient body areas and associated tissues, as well as sensors for monitoring treatment progress and dosage optimization. Methods of delivering light therapy to a patient and treatment of associated medical indications are also set out herein. Personalized LLLT dosage configurations and telemedicine LLLT treatment platforms and systems are also provided herein.
    Type: Grant
    Filed: March 16, 2021
    Date of Patent: October 4, 2022
    Inventor: Jack K. Zhang
  • Patent number: 11452808
    Abstract: Devices and methods for collecting and sensing fluid flow are provided.
    Type: Grant
    Filed: July 7, 2017
    Date of Patent: September 27, 2022
    Inventors: Robert Gordon Maurice Selby, Arnau Perdigo-Oliveras, Roderick Marcus Van Den Bergh
  • Patent number: 11452883
    Abstract: A hands-free LED device for the treatment of wrinkles and acne, or hair loss, includes a curved housing. Rigid areas contain the LED bulbs. The LED bulbs are interspaced therebetween the flexible areas; such that between each of the rigid LED bulb areas is a flexible area. The rigid LED bulb areas are between the flexible areas. A leg is provided on opposite sides of the housing, The legs being wider at the top of each leg and narrower at the bottom. The number of LED bulbs at each wavelength for treatment of wrinkles are: 126 LED bulbs of 605 nm; 210 LED bulbs of 630 nm, 126 LED bulbs of 660 nm, and 26 LED bulbs of 850 nm. The number of LED bulbs at each wavelength for treatment of acne are 280 LED bulbs at 415 nm and 210 LED bulbs of 630 nm. Hair loss uses 500-700 LED bulbs at 630 nm.
    Type: Grant
    Filed: February 25, 2022
    Date of Patent: September 27, 2022
    Inventors: Stephen James Marchese, Chasen James Marchese
  • Patent number: 11445972
    Abstract: According to various aspects, a new concept of Steady-State Visually Evoked Potential (SSVEP) based Brain-Computer Interface (BCI) is described where brain-computer communication occurs by capturing SSVEP induced by consciously imperceptible visual stimuli integrated into, for example, a virtual scene. These consciously imperceptible visual stimuli are able to convey subliminal information to a computer. In various embodiments, computer based operations can be mapped to visual elements with associated flickering stimuli, and induced SSVEP can be detected when the user focused upon them. In various embodiments, these visual elements can be introduced into existing display without any perceivable change to content being displayed.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: September 20, 2022
    Assignee: Massachusetts Institute of Technology
    Inventors: Sanjay E. Sarma, Alex Armengol Urpi
  • Patent number: 11446512
    Abstract: An adjustable illuminator for photodynamically diagnosing or treating a surface includes a plurality of first panels and at least one second panel. The plurality of first panels have wider widths and the at least one second panel has a narrower width. The narrower width is less than the wider widths. The illuminator further includes a plurality of light sources, each mounted to one of the plurality of first panels or the at least one second panel and configured to irradiate the surface with substantially uniform intensity visible light. The plurality of first panels and the at least one second panel are rotatably connected. The at least one second panel is connected on each side to one of the plurality of first panels. The second panel acts as a “lighted hinge” to reduce or eliminate optical dead spaces between adjacent panels when the illuminator is bent into a certain configuration.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: September 20, 2022
    Assignee: DUSA PHARMACEUTICALS, INC.
    Inventors: Thomas Boyajian, Mark Carota, Brian Mazejka
  • Patent number: 11446465
    Abstract: Systems and methods for adjusting a user's circadian rhythm are provided. In some embodiments, a system may be configured to obtain information relating to the user's present circadian rhythm and information relating to one or more anticipated times of sleep and/or wakefulness. The system may generate a model for estimating the user's circadian rhythm. The system may also generate a model for estimating the user's homeostatic sleep drive. Based on one or both models, the system may generate instructions for activating the light source to adjust the user's circadian rhythm.
    Type: Grant
    Filed: December 10, 2021
    Date of Patent: September 20, 2022
    Assignee: LumosTech, inc.
    Inventor: Biquan Luo
  • Patent number: 11446513
    Abstract: A method for treating autism. Light energy is applied externally to a patient's scalp on the skull near the frontal lobes. Optionally the light is also applied to the temporal lobes and the base of the brain. The treatment can be enhanced by activating the cranial nerves while the light is applied. In a preferred embodiment the applied light is in the red range and more preferably about of 635 nm±10 nm. In a preferred embodiment, the applied light energy is applied with a pulse frequency or frequencies of 8 Hz, 53 Hz, 73 Hz and 101 Hz. The light can be emitted from the same light emitter or from multiple emitters. Preferably the light is laser light and is emitted as a line from a hand-held laser device, and the line is waved manually across a person's skull in the desired area in a continuous, sweeping manner.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: September 20, 2022
    Assignee: Erchonia Corporation, LLC
    Inventor: Steven C Shanks
  • Patent number: 11439840
    Abstract: A far ultraviolet light application device for killing pathogens on tissue and proximate thereto includes a tube that is to be utilized in a medical procedure. A first fiberoptic cable is engaged to a wall of the tube so that a first end of the first fiberoptic cable is positioned proximate to a first terminus of the tube. The first fiberoptic cable has a second end operationally engaged an ultraviolet C light emitter so that ultraviolet C light is emitted proximate to the first terminus of the tube. The first fiberoptic cable directs the ultraviolet C light from the ultraviolet C light emitter so that the ultraviolet C light impinges upon tissue and pathogens proximate to the first terminus of the tube to inactivate the pathogens.
    Type: Grant
    Filed: January 21, 2021
    Date of Patent: September 13, 2022
    Inventor: Joseph McQuirter, Sr.
  • Patent number: 11426600
    Abstract: Photobiomodulation therapy (PBMT) can be applied to a dystrophic muscle to delay dystrophy progression. A light source device can be contacted to a subject's skin proximal to a dystrophic muscle or muscle group. A light signal (with wavelengths from the red to infrared part of the spectrum) can be applied in at least one of a pulsed operating mode, a continuous operating mode, and a super-pulsed operating mode through the light source device to the dystrophic muscle or muscle group. The light signal is applied for a time sufficient to stimulate a phototherapeutic response in the dystrophic muscle or muscle group.
    Type: Grant
    Filed: April 13, 2018
    Date of Patent: August 30, 2022
    Assignee: MULTI RADIANCE MEDICAL
    Inventors: Douglas Johnson, Max Kanarsky, Ernesto Leal-Junior
  • Patent number: 11394226
    Abstract: Devices, systems, and techniques for monitoring the temperature of a device used to charge a rechargeable power source are disclosed. Implantable medical devices may include a rechargeable power source that can be transcutaneously charged. The temperature of an external charging device and/or an implantable medical device may be monitored to control the temperature exposure to patient tissue. In one example, a temperature sensor may sense a temperature of a portion of a device, wherein the portion is non-thermally coupled to the temperature sensor. A processor may then control charging of the rechargeable power source based on the sensed temperature.
    Type: Grant
    Filed: December 7, 2020
    Date of Patent: July 19, 2022
    Assignee: Medtronic, Inc.
    Inventors: Peng Cong, Venkat R. Gaddam, David P. Olson, Erik R. Scott, Todd V. Smith, Leroy L. Perz
  • Patent number: 11383095
    Abstract: Systems and methods for phototherapeutic modulation of nitric oxide in mammalian tissue include use of a first wavelength and first radiant flux of light to stimulate enzymatic generation of nitric oxide, and use of a second wavelength and second radiant flux of light to stimulate release of nitric oxide from endogenous stores of nitric oxide. Pulsed light and/or partially non-overlapping light impingement windows may be used. Non-coherent light impinged on tissue may include a peak wavelength in a range of from 410 nm to 440 nm in the absence of light emissions having a peak wavelength of from 600 nm to 900 nm.
    Type: Grant
    Filed: December 10, 2019
    Date of Patent: July 12, 2022
    Assignee: KNOW Bio, LLC
    Inventors: Nathan Stasko, Nicholas William Medendorp, Jr., Gerald H. Negley, Katelyn P. Reighard
  • Patent number: 11375588
    Abstract: Disclosed herein are system, apparatus, article of manufacture, method and/or computer program product embodiments, and/or combinations and sub-combinations thereof, for a dimmer device including a driver, and a controller communicatively coupled to the driver and to a monitor device. The monitor device can include a camera and is configured to take a plurality of images of the illumination load. The controller provides a control signal that indicates to the driver to adjust power supplied to an illumination load. The control signal is provided in response to a determination that a performance of the illumination load fails to satisfy a predetermined performance indicator. The performance of the illumination load is determined based on information related to the plurality of images of the illumination load taken by the camera of the monitor device. The controller can adjust a dimming level of the illumination load by providing the control signal to the driver.
    Type: Grant
    Filed: November 18, 2021
    Date of Patent: June 28, 2022
    Assignee: Roku, Inc.
    Inventor: Gregory Mack Garner
  • Patent number: 11357407
    Abstract: In a photoacoustic apparatus, a light source irradiates an inspection target with pulsed light; a detector detects acoustic waves generated in the inspection target due to interaction of the pulsed light with the inspection target, and outputs detection signals corresponding to the detected acoustic waves; a light-quantity measurement unit measures the quantity of the light output from the light source; and a signal processor obtains information on an inside of the inspection target by using the detection signals output from the detector. The signal processor also corrects intensities of the detection signals so as to suppress variations in intensities of the detection signals caused by a temporal change in the quantity of the light.
    Type: Grant
    Filed: August 8, 2019
    Date of Patent: June 14, 2022
    Assignee: Canon Kabushiki Kaisha
    Inventor: Yasuhiro Someda
  • Patent number: 11357406
    Abstract: The instrument according to the invention for electrosurgically impacting biological tissue comprises an electrode (18) as well as a light guide (21), which is connected to a light inlet window (19), which is formed by means of a fluid body (27). The light guide is connected to a light analysis device (13), so as to absorb the light, which is generated at the electrode (18) in response to the HF surgery and so as to supply it to the light analysis device (13). The light inlet window (19) is arranged at the point of origin of the light, namely immediately at the electrode, that is, at the spark, which is generated. An adulteration of the absorbed light by means of smoke or particle deposition on the light inlet window (19) can virtually be avoided.
    Type: Grant
    Filed: November 26, 2018
    Date of Patent: June 14, 2022
    Assignee: Erbe Elektromedizin GmbH
    Inventors: Klaus Fischer, Alexander Neugebauer, Dominik Spether, Markus Enderle
  • Patent number: RE49724
    Abstract: A method and device for photodynamic therapy for treating cancer. The method includes: providing a photodynamic therapeutic device for treating cancer. The provided device includes a plurality of light emitting diodes that are positionable in proximity of a patient's body and are adapted to provide a light fluence to a lesion area. The method also includes administering an effective dose of a photosensitizer in the lesion area; positioning the device in proximity to the patient's body; and irradiating the patient's body.
    Type: Grant
    Filed: July 29, 2019
    Date of Patent: November 14, 2023
    Inventor: Tom Kerber